Lacrifill for Ocular Surface Optimization in Cataract Surgery
Part of paid clinical trials in Largo, Florida.
- Sponsor
- The Eye Institute of West Florida
- Study ID
- NCT07648095
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cataract
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Lacrifill Canalicular Filler — DEVICELacrifill Canalicular Filler
Study Details
This is a single-site observational study designed to evaluate the efficacy of Lacrifill™ canalicular filler in optimizing ocular surface parameters and biometric precision in prospective cataract surgery patients with dry eye disease (DED).
Key Dates
- Start date
- Jul 15, 2026
- Status verified
- Jun 2026
- Primary completion
- Jul 15, 2027
- Completion
- Jul 15, 2027
Study Design
- Enrollment
- 65 participants (estimated)
Arms
- Arm: Lacrifill Canalicular FillerObservational Study
Primary Outcome Measure
Mean absolute error (MAE) [ Time Frame: 1 month postoperatively ]
Central Contacts
- Renee Bondurant727-450-4668
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The Eye Institute of West Florida | Largo | Florida | 33770 | Neel R Desai, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Largo, FL
By research site
Related Studies
- IC-8 Apthera IOL New Enrollment Post Approval StudyRecruiting · Bausch & Lomb Incorporated · Dothan, Alabama
- A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)PHASE3 · Recruiting · Melt Pharmaceuticals · Chico, California
- Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL+Not Yet Recruiting · The Eye Associates · Bradenton, Florida
- Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOCPHASE1/PHASE2 · Recruiting · Inder Paul Singh, M.D. · Venice, Florida